Justification FAR Part 13 (JA) FINAL_W81K0025QA169_FINAL_Redacted.pdf

3 MB Posted

Attached to
Radiopharmaceuticals
Solicitation number
W81K00-25-D-A008
Issued by

About this file

Written by GovTribe AI ·

This Justification Review Document details a noncompetitive sole-source procurement for radiopharmaceuticals by the Medical Readiness Contracting Office - West (MRCO-W) for the Department of Radiology, Nuclear Medicine at Brooke Army Medical Center (BAMC) in Fort Sam Houston, Texas. The proposed contract is with Cardinal Health 414, LLC for a four-year ordering period from October 1, 2025 to September 30, 2029, funded by Defense Health Program (DHP) funds, with a total value that is redacted.

The requirement is specifically for radiopharmaceuticals used in imaging and therapeutics for cancer patients, which must be prepared in a USP 825 compounding environment and delivered 24 hours a day/7 days a week to the installation. Cardinal Health 414, LLC is the only pharmacy in the local San Antonio area capable of meeting these stringent delivery requirements, located approximately 20 miles from BAMC. Market research and a sources sought notice revealed no alternative vendors, with another pharmacy (RLS Pharmacies) being too far away to provide timely delivery. The contract is being pursued under simplified procedures for commercial items, with the justification emphasizing the critical nature of these radiopharmaceuticals for patient care.

View the file

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file
Try for free Login

Text version

The file's text, extracted by GovTribe without its formatting.

CUI//SP-PROCURE//FEDCON

JUNE 2025

radiopharmaceuticals, the pharmacy must be local to meet delivery and distribution requirements.

1) Cardinal Health 414, LLC is the only pharmacy in the local San Antonio area providing radiopharmaceuticals. Cardinal Health 414, LLC is located approximately 20 miles from BAMC and delivers the required radiopharmaceuticals 24 hours a day/7days a week.

b. Alternatives: There are no alternatives to procure the radiopharmaceuticals.

Cardinal Health 414, LLC has the only pharmacy in the local area able to meet the requirement. The current Blanket Purchase Agreement (BPA) was awarded to Cardinal Health 414, LLC.

c. Impact if not approved: Failure to approve this justification would jeopardize the mission of BAMC and its military community. Nuclear Medicine would not be able to provide quality timely care to its prostate cancer patients.

7. Efforts to Obtain Competition: The Contracting Officer has published the notices required by FAR 5.201 and any bids or proposals received shall be considered. A sources sought notice was posted to www.SAM.gov on 31 Jul 2025 with a closing date of 7 Aug 2025. Responses were received from two vendors:

a) Cardinal Health 414, LLC (CAGE: 3S229) � Cardinal Health 414, LLC submitted a capabilities statement. Cardinal Health 414, LLC is located in San Antonio, TX and approximately 20 miles from BAMC.

b) RLS Pharmacies (CAGE: 8JQE2) - RLS Pharmacies submitted a capabilities statement. The pharmacy is located in Temple, TX and approximately 150 miles from BAMC. It was determined by the customer that RLS Pharmacies� location is outside the local area and unable to provide delivery to BAMC. The pharmacy must be local to provide the radiopharmaceuticals during duty hours and after-hours.

A notice of intent to sole source to Cardinal Health 414, LLC was posted on www.SAM.gov on 11 Aug 2025. No response received.

a. Effective competition: Based on market research and the results of the sources sought and notice of intent, competition is not anticipated for this requirement. The J&A will be posted within 14 days after contract award. The Government will continue to assess the market for new entrants.

b. Subcontracting competition: Due to the nature of the requirement, subcontracting opportunities are not available.

8. Market Research: In accordance with FAR Part 10, market research has been conducted for this acquisition. Market research was conducted in July 2025 by the

JUNE 2025

5) An explanation of any unusual patterns that may be revealed by the history, e.g., several consecutive, urgent buys. N/A

6) An explanation of protests received, if applicable, and actions taken in response to the protest. N/A

b. Other facts. N/A

File details come from the government source that posted it. Updated .